-
Thomson American Health Consultants is offering an audio conference with the information necessary to help you recognize the ethical and regulatory issues related to working with children in clinical trials.
-
Slips, trips, and falls happen in any health care setting, and they can be enormously expensive. The good news is that you can sharply reduce those accidents by aggressively employing some rather simple strategies.
-
This case highlights the problems that can stem from traumatic lacerations, a common childhood injury.
-
The U.S. Attorneys office in Western District of Washington state has announced that Richard W. Gibson, 42, of SeaTac, WA, pleaded guilty in federal court in Seattle to wrongful disclosure of individually identifiable health information for economic gain. The case is the first criminal conviction related to the health information privacy provisions of HIPAA that became effective in April 2003.
-
A major nationwide study has found that the long hours worked by hospital staff nurses may have adverse effects on patient safety.
-
Munger and colleagues reviewed a database of 187,563 women enrolled in the Nurses Health Study, which longitudinally surveyed participants aged 25-55. There were 173 women with probable or definite multiple sclerosis (MS). Vitamin D intake was determined through the study questionnaire and 4 1-week diet records.
-
Hepatocellular carcinoma is one of the most common malignancies worldwide, and, for those with advanced disease, treatment responses have been dismal. The current report of a trial of gemcitabine and oxaliplatin offers some hope. Using 2 different schedules of these agents, this study found an approximate 20% objective response rate with stable disease occurring in an additional 50%.
-
-
In the year 2000, Health Care Financing Administration (now known as the Centers for Medicare & Medicaid Services) issued its National Coverage Determination (NCD) extending Medicare coverage to routine costs of qualifying trials, as well as those items and services made necessary to diagnose or treat complications arising from clinical trial participation.
-
Patients with elevated bilirubin treated with irinotecan have an increased risk of toxicity, and a dose reduction is recommended. Patients with elevated AST, creatinine or prior pelvic radiation do not appear to have increased sensitivity to irinotecan, but the data are not adequate to support a specific dosing recommendation.